四分之三的乳腺癌肿瘤由雌性激素驱动所致。为了抑制雌激素受体活性,常常给予药物治疗,但至少有一半的患者对这些治疗无应答,结果发展成为耐药性肿瘤。目前,斯克里普斯研究所(TSRI)、加利福尼亚大学(UC)、圣地亚哥和伊利诺伊大学佛罗里达州校区的科学家发现,两种免疫系统分子可能是雌激素驱动的乳腺癌中进展 Three-quarters of breast cancer tumors are caused by estrogen. In order to inhibit estrogen receptor activity, drug treatment is often given, but at least half of these patients do not respond to these treatments and as a result develop into drug-resistant tumors. Currently, scientists at the Scripps Research Institute (TSRI), the University of California (UC), San Diego and the University of Illinois at Florida found that both immune system molecules are likely to progress in estrogen-driven breast cancer